Skip to main content

Expanding Our Reach. Strengthening Our Impact.
LGDA is now the Lymphatic Malformations Alliance. Discover the next chapter of our mission. 

Patients/Caregivers

KLA and the Discovery of Angiopoientin-2 as a Biomarker Disease

Learn about Michael's journey, a young boy diagnosed with Kaposiform Lymphangiomatosis Anomaly (KLA). Michael’s parents share how their son’s journey was impacted by research on markers of disease in the laboratory of Timothy LeCras, PhD, at Cincinnati Children’s Hospital. Dr. LeCras is Associate Professor, UC Department of Pediatrics.

Be Part of What Comes Next

Together, patients, families, clinicians, and researchers are changing the future of lymphatic malformations. 

Your donation helps make that progress possible.

MENU CLOSE